As filed with the Securities and Exchange Commission on November 7, 1997
Registration No. 333-
==============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Laboratory Corporation of America Holdings
(Exact Name of issuer as specified in its charter)
Delaware 13-3757370
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
358 South Main Street
Burlington, North Carolina 27215
(910) 229-1127
(Address of principal executive offices)
--------------------
Laboratory Corporation of America Holdings
1997 Stock Option Plan
(Full title of the Plan)
--------------------
Bradford T. Smith
Executive Vice President, General Counsel
Corporate Compliance Officer and Secretary
Laboratory Corporation of America Holdings
358 South Main Street
Burlington, North Carolina 27215
(Name and address of agent for service)
Telephone number, including area code, of agent
for service: (910) 229-1127
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
=======================================================================================================
Proposed Proposed
Maximum Maximum
Offering Aggregate Amount of
Title of Securities Amount to be Price Per Offering Registration
to be Registered Registered* Share** Price** Fee
- -------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Common Stock (par value 6,000,000 shares $2.4375 $14,625,000 $5,043.10
$.01 per share).............
=======================================================================================================
</TABLE>
* Plus an indeterminate number of additional shares which may be offered and
issued to prevent dilution resulting from stock splits, stock dividends or
similar transactions
** Estimated pursuant to Rule 457 of the General Rules and Regulations under
the Securities Act of 1933 solely for the purpose of computing the
registration fee, based on the average of the high and low sale prices of
the securities being registered hereby on the Composite Tape on
November 6, 1997.
==============================================================================
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
Laboratory Corporation of America Holdings (the "Company")
hereby incorporates herein by reference the following documents:
(1) The Company's Annual Report on Form 10-K for the fiscal
year ended December 31, 1996;
(2) All reports filed pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), since
December 31, 1996;
(3) The description of the Company's Common Stock contained in
Amendment No. 1 to the Company's Registration Statement on Form 8-B dated
April 27, 1995, filed under the Exchange Act, including any amendment thereto
or report filed for the purpose of updating such description; and
(4) All documents filed by the Company pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this
Registration Statement and prior to the filing of a post-effective amendment
which indicates that all securities offered herein have been sold or which
deregisters all securities then remaining unsold.
INDEMNIFICATION OF DIRECTORS AND OFFICERS
Reference is made to Section 102(b)(7) of the Delaware General
Corporation Law (the "DGCL"), which enables a corporation in its original
certificate of incorporation or an amendment thereto to eliminate or limit the
personal liability of a director for violations of the director's fiduciary
duty, except (i) for any breach of the director's duty of loyalty to the
corporation or its stockholders, (ii) for acts or omissions not in good faith
or which involve intentional misconduct or a knowing violation of law, (iii)
pursuant to Section 174 of the DGCL (providing for liability of directors for
the unlawful payment of dividends or unlawful stock purchases or redemptions)
or (iv) for any transaction from which a director derived an improper personal
benefit.
Section 145 if the DGCL empowers the Company to indemnify,
subject to the standards set forth therein, any person in connection with any
action, suit or proceeding brought before or threatened by reason of the fact
that the person was a director, officer, employee or agent of such company, or
is or was serving as such with respect to another entity at the request of
such company. The DGCL also provides that the Company may purchase insurance
on behalf of any such director, officer, employee or agent.
The Company's Certificate of Incorporation provides in effect
for the indemnification by the Company of each director and officer of the
Company to the fullest extent permitted by applicable law.
EXHIBITS
The following is a complete list of exhibits filed as part of
this Registration Statement:
Exhibit No.
- ----------
4.1 Certificate of Incorporation of the Company (incorporated by
reference to Exhibit 3.1 to the Current Report on Form 8-K
filed with the Securities and Exchange Commission on May 12,
1995 (the "Form 8-K")
4.2 By-Laws of the Company (incorporated by reference to Exhibit
3.2 to the Form 8-K)
4.3 1997 Stock Option Plan
5 Opinion of Davis Polk & Wardwell
23.1 Consent of KPMG Peat Marwick LLP
23.2 Consent of Davis Polk & Wardwell (included in Exhibit 5)
24 Powers of Attorney
UNDERTAKINGS
(a) The undersigned registrant hereby undertakes:
(1) to file, during any period in which offers or sales are being made,
a post-effective amendment to this registration statement:
(i) To include any prospectus required by Section 10(a)(3) of the
Securities Act of 1933 (the "Securities Act");
(ii) To reflect in the prospectus any facts or events arising after the
effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the
registration statement; and
(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement; and
provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if
the information to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed by the registrant pursuant
to Section 13 or Section 15(d) of the Exchange Act that are incorporated by
reference in the registration statement.
(2) that, for the purpose of determining any liability under
the Securities Act, each such post-effective amendment shall be deemed to be a
new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial
bona fide offering thereof; and
(3) to remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the
termination of the offering.
(b) The undersigned registrant hereby undertakes that, for
purposes of determining any liability under the
Securities Act, each filing of the registrant's Annual
Report pursuant to Section 13(a) or Section 15(d) of the
Exchange Act (and, where applicable, each filing of an
employee benefit plan's Annual Report pursuant to
Section 15(d) of the Exchange Act) that is incorporated
by reference in the registration statement shall be
deemed to be a new registration statement relating to
the securities offered therein, and the offering of such
securities at that time shall be deemed to be the
initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under
the Securities Act may be permitted to directors,
officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification
is against public policy as expressed in the Act and is,
therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the
payment by the registrant of expenses incurred or paid
by a director, officer or controlling person of the
registrant in the successful defense of any action, suit
or proceeding) is asserted by such director, officer or
controlling person in connection with the securities
being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act
and will be governed by the final adjudication of such
issue.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Burlington, State of North Carolina,
on the 7th day of November, 1997.
LABORATORY CORPORATION OF AMERICA HOLDINGS
By /s/ Thomas P. Mac Mahon
------------------------------------------
Thomas P. Mac Mahon
Chairman of the Board, President and Chief
Executive Officer
Pursuant to the requirements of the Securities Act of 1933,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
Signature Title Date
--------- ----- -------------
<S> <C> <C>
/s/ Thomas P. Mac Mahon Chairman of the Board, President, Chief November 7, 1997
- --------------------------- Executive Officer and Director
Thomas P. Mac Mahon
/s/ * Executive Vice President, Chief November 7, 1997
- --------------------------- Financial Officer and Treasurer
Wesley R. Elingburg (Principal Accounting and Financial
Officer)
/s/ * Director November 7, 1997
- ---------------------------
Jean-Luc Belingard
/s/ * Director November 7, 1997
- ---------------------------
Wendy E. Lane
/s/ * Director November 7, 1997
- ---------------------------
Robert E. Mittelstaedt, Jr.
/s/ * Director November 7, 1997
- ---------------------------
James B. Powell, M.D.
/s/ * Director November 7, 1997
- ---------------------------
David B. Skinner, M.D.
/s/ * Director November 7, 1997
- ---------------------------
Andrew G. Wallace, M.D.
*By: /s/ Thomas P. Mac Mahon
-----------------------
Thomas P. Mac Mahon
Attorney-in-Fact
</TABLE>
INDEX TO EXHIBITS
The following is a complete list of exhibits filed as part of
this Registration Statement:
<TABLE>
<CAPTION> Sequentially
Exhibit Numbered
Number Exhibit Page
- ------- ------- ------------
<S> <C> <C>
4.1 Certificate of Incorporation of the Company (incorporated by reference to
Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and
Exchange Commission on May 12, 1995 (the "Form 8-K")
4.2 By-Laws of the Company (incorporated by reference to Exhibit 3.2 to the Form
8-K)
4.3 1997 Stock Option Plan........................................................ 8
5 Opinion of Davis Polk & Wardwell.............................................. 16
23.1 Consent of KPMG Peat Marwick LLP.............................................. 17
23.2 Consent of Davis Polk & Wardwell (included in Exhibit 5)...................... 16
24 Powers of Attorney............................................................ 18
</TABLE>
EXHIBIT 4.1
LABORATORY CORPORATION OF AMERICA HOLDINGS
1997 STOCK OPTION PLAN
1. Purpose; Restrictions on Amount Available under the Plan.
This 1997 Stock Option Plan ("Plan") is intended to encourage
stock ownership by employees of Laboratory Corporation of America Holdings
(the "Company") and employees of Affiliated Corporations (as defined in Section
2(a) hereof), so that they may acquire or increase their proprietary interest
in the Company, and to encourage such employees to remain in the employ of the
Company and to put forth maximum efforts for the success of the business. It
is further intended that options granted by the Committee pursuant to Section
6 of this Plan shall constitute "incentive stock options" ("Incentive Stock
Options") within the meaning of Section 422 of the Internal Revenue Code of
1986, as thereafter amended, and the regulations issued thereunder (the
"Code"), and options granted by the Committee pursuant to Section 7 of this
Plan shall constitute "nonqualified stock options" ("Nonqualified Stock
Options"). Grants under this Plan may consist of Incentive Stock Options,
Nonqualified Stock Options (collectively, "Options") or stock appreciation
rights ("Rights"), which Rights may be either granted in conjunction with
Options ("Related Rights") or unaccompanied by Options ("Free Standing
Rights"), as hereinafter set forth.
2. Definitions.
As used in this Plan, the following words and phrases shall
have the meanings indicated:
(a) "AFFILIATE CORPORATION" or "AFFILIATE" shall mean any corporation,
directly or indirectly, through one or more intermediaries, controlling,
controlled by, or under common control with the Company.
(b) "CHANGE IN CONTROL" shall mean circumstances under which Roche
Holding Ltd. or any corporation directly or indirectly, through one or more
intermediaries, controlling, controlled by, or under common control with Roche
Holding Ltd. ceases to maintain "beneficial ownership" (as defined in Rule
13d-3 of the Exchange Act), individually or in the aggregate, of securities
of the Company representing five percent (5%) or more of the combined voting
power of the Company's then outstanding securities.
(c) "DISABILITY" shall mean an optionee's inability to engage in any
substantial gainful activity by reason of medically determinable physical or
mental impairment that can be expected to result in death or that has lasted
or can be expected to result in death or that has lasted or can be expected to
last for a continuous period of not less than twelve (12) months.
(d) "EXCHANGE ACT" shall mean the Securities Exchange Act of 1934, as
amended.
(e) "FAIR MARKET VALUE" per share as of a particular date shall mean (i)
the closing sales price per share of Common Stock (as defined in Section 5
hereof) on a national securities exchange for the last preceding date on which
there was a sale of such Common Stock on such exchange, or (ii) if the shares
of Common Stock are then traded on an over-the-counter market, the average of
the closing bid and asked prices for the shares of Common Stock in such
over-the-market for the last preceding date on which there was a sale of such
Common Stock in such market, or (iii) if the shares of Common Stock are not
then listed on a national securities exchange or traded in an over-the-counter
market, such value as the Committee in its discretion may determine.
(f) "PARENT CORPORATION" shall mean any corporation (other than the
Company) in an unbroken chain of corporations ending with the Company if, at
the time of granting an Option , each of such corporations (other than the
Company) owns stock possessing fifty percent (50%) or more of the total
combined voting power of all classes of stock in one of the other corporations
in such chain.
(g) "RETIREMENT" shall mean an optionee's termination of employment in
accordance with the provisions of the Company's Employee Retirement Plan at
such Optionee's Normal Retirement Date, as defined in such plan.
(h) "SUBSIDIARY CORPORATION" shall mean any corporation (other than the
Company) in an unbroken chain of corporations beginning with the Company if,
at the time of granting an option, each of such corporations other than the
last corporation in the unbroken chain owns stock possessing fifty percent
(50%) or more of the total combined voting power of all classes of stock in
one of the other corporations in such chain.
(i) "TEN PERCENT STOCKHOLDER" shall mean an Optionee who, at the time an
Incentive Stock Option is granted, owns stock possessing more than ten percent
(10%) of the total combined voting power of all classes of stock of the
Company or of its Parent Corporation or Subsidiary corporations.
3. Administration.
The Plan shall be administered by a committee (the "Committee")
appointed by the Board of Directors of the Company (the "Board"), which shall
be comprised of three or more persons, each of whom shall qualify as a
"Non-Employee Director" as described in Rule 16b-3(b)(3)(i) promulgated under
the Exchange Act.
The Committee shall have the authority in its discretion,
subject to and not inconsistent with the express provisions of the Plan, to
administer the Plan and to exercise all the powers and authorities either
specifically granted to it under the Plan or necessary or advisable in the
administration of the Plan, including, without limitation, the authority to
grant Options; to determine which Options shall constitute Incentive Stock
Options and which Options shall constitute Nonqualified Stock Options; to
determine which Rights (if any) shall be granted in conjunction with Options;
to determine the purchase price of the shares of Common Stock covered by each
Option (the "Option Price"); to determine the persons to whom, and the time or
times at which, Options shall be granted; to determine the number of shares to
be covered by each Option; to interpret the Plan; to prescribe, amend and
rescind rules and regulations relating to the Plan; to determine the terms and
provisions of the agreements (which need not be identical) entered into in
connection with Options and/or Rights granted under the Plan ("Option
Agreements"); and to make all other determinations deemed necessary or
advisable for the administration of the Plan. The Committee may delegate to
one or more of its members or to one or more agents such administrative duties
as may be deemed advisable, and the Committee or any person to whom it has
delegated duties as aforesaid may employ one or more persons to render advice
with respect to any responsibility the Committee or such person may have under
the Plan.
No member of the Board of Directors or Committee shall be
liable for any action taken or determination made in good faith with respect
to the Plan or any Option or Right granted hereunder.
4. Eligibility.
Options, Rights, or both Options and Rights may be granted to
key employees (including, without limitation, officers and directors who are
employees) of the Company or its present or future Affiliate Corporations,
except that Incentive Stock Options shall be granted only to individuals who,
on the date of such grant, are employees of the Company or a Parent
Corporation or a Subsidiary Corporation. In determining the persons to whom
Options and/or Rights shall be granted and the number of shares to be covered
by each option and any Rights, the Committee shall take into account the
duties of the respective persons, their present and potential contributions to
the success of the Company and such other factors as the Committee shall deem
relevant in connection with accomplishing the purpose of the Plan. A person to
whom an Option has been granted hereunder is sometimes referred to herein as
an "Optionee."
An Optionee shall be eligible to receive more than one grant of
an Option during the term of the Plan, but only on the terms and subject to
the restrictions hereinafter set forth.
5. Stock.
The stock subject to Options and Rights hereunder shall be
shares of the Company's common stock, par value $0.01 per share ("Common
Stock"). Such shares may, in whole or in part, be authorized but unissued
shares or shares that shall have been or that may be reacquired by the
Company. The aggregate number of shares of Common Stock as to which Options
and Rights may be granted from time to time under the Plan shall not exceed
6,000,000. No person may be granted Options or Rights under the Plan
representing an aggregate of more than 750,000 shares of Common Stock in any
year. The limitations established by the preceding two sentences shall be
subject to adjustment as provided in Section 8(i) hereof.
To the extent that (1) any Option expires or is terminated
without being exercised or surrendered, (2) any option is surrendered on
exercise of a Right for cash or the issuance of fewer shares of Common Stock
than issuable under such surrendered Option or (3) any Free Standing Right
expires or is terminated without being exercised, the shares of Common Stock
issuable thereunder, less such shares issued, shall become available for
grants of options or Rights.
6. Incentive Stock Options.
Options granted pursuant to this Section 6 are intended to
constitute Incentive Stock Options and shall be subject to the following
special terms and conditions, in addition to the general terms and conditions
specified in Section 8 hereof.
(a) VALUE OF SHARES. The aggregate Fair Market Value (determined as of
the date the Incentive Stock Option is granted) of the shares of Common Stock
with respect to which Options granted under this Plan and all other option
plans of the Company, any Parent Corporation and any Subsidiary Corporation
become exercisable for the first time by an optionee during any calendar year
shall not exceed $100,000.
(b) TEN PERCENT STOCKHOLDERS. In the case of an Incentive Stock Option
granted to a Ten Percent Stockholder, (i) the Option Price shall not be less
than one hundred ten percent (110%) of the Fair Market Value of a share of
Common Stock of the Company on the date of grant of such Incentive Stock
Option, and (ii) the exercise period shall not exceed five (5) years from the
date of grant of such Incentive Stock Option.
7. Nonqualified Stock Options.
Options granted pursuant to this Section 7 are intended to
constitute Nonqualified Stock Options and shall be subject only to the general
terms and conditions specified in Sections 5 and 8 hereof.
8. Terms and Conditions of Options.
Each Option granted pursuant to the Plan shall be evidenced by
a written Option Agreement between the Company and the optionee, which
agreement shall comply with and be subject to the following terms and
conditions:
(a) NUMBER OF SHARES. Each Option Agreement shall state the number of
shares of Common Stock to which the Option relates.
(b) TYPE OF OPTION. Each Option agreement shall specifically identify
the portion, if any, of the option which constitutes an Incentive Stock Option
and the portion, if any, which constitutes a Nonqualified Stock Option.
(c) OPTION PRICE. Each Option Agreement shall state the Option Price
per share of Common Stock, which shall be not less than one hundred percent
(100%) of the Fair Market Value of a share of Common Stock of the Company on
the date of grant of the Option and which, in the case of Incentive Stock
Options, shall be further subject to the limitation described in Section 6(b)
hereof. The Option Price shall be subject to adjustment as provided in
Section 8(i) hereof. The date on which the Committee adopts a resolution
expressly granting an option shall be considered the day on which such option
in granted.
(d) MEDIUM AND TIME OF PAYMENT. The Option Price shall be paid in full,
at the time of exercise, in cash or in shares of Common Stock having a Fair
Market Value equal to such Option Price or in a combination of cash and such
shares, and may be effected in whole or in part, at the discretion of the
Committee (i) with monies received from the Company at the time of exercise as
a compensatory cash payment, or (ii) with monies borrowed from the Company
pursuant to repayment terms and conditions as shall be determined from time
to time by the Committee, in its discretion separately with respect to each
exercise of options and each optionee; provided, however, that each such
method and time for payment and each such borrowing and terms and conditions
of security, if any, and repayment shall be permitted by and be in compliance
with applicable law.
(e) TERM AND EXERCISE OF OPTIONS. Options shall be exercised over the
exercise period as and at the times and upon the conditions that the Committee
may determine, as reflected in the Option Agreement; provided, however, that
the Committee shall have the authority to accelerate the exercisability of any
outstanding option at such time and under such circumstances as it, in its
sole discretion, deems appropriate. The exercise period shall be determined
by the Committee; provided, however, that in the case of any Incentive Stock
Option, such exercise period shall not exceed ten (10) years from the date of
grant of such Incentive Stock Option and such exercise period shall be further
limited in circumstances described in Section 6(b) hereof. The exercise
period shall be subject to earlier termination as provided in Section 8(f) and
8(g) hereof. An Option may be exercised as to any or all full shares of
Common Stock as to which the Option has become exercisable, by giving written
notice of such exercise to the Committee; provided, however, that an Option
may not be exercised at any one time as to fewer than one hundred (100) shares
(or such number of shares as to which the Option is then exercisable if such
number of shares is less than one hundred (100)).
(f) TERMINATION OF EMPLOYMENT. Except as provided in this Section 8(f)
and in Section 8(g) hereof, an Option may not be exercised unless the Optionee
is then in the employ of (1) the Company, (2) an Affiliate Corporation or (3)
a corporation issuing or assuming the Option in a transaction to which Section
424 of the Code applies or a parent corporation or subsidiary corporation of
the corporation described in this Clause 3, and unless the Optionee has
remained continuously so employed since the date of grant of the Option. In
the event that the employment of an Optionee shall terminate (other than by
reason of death, Disability or Retirement), all options of such Optionee that
are exercisable at the time of such termination may, unless earlier terminated
in accordance with their terms, be exercised within three (3) months after
such termination. Nothing in the Plan or in any Option or Right granted
pursuant hereto shall confer upon an individual any right to continue in the
employ of the Company or any of its Affiliate Corporations or interfere in any
way with the right of the Company or any such Affiliate Corporation to
terminate such employment at any time.
(g) ACCELERATION OF BENEFITS UPON DEATH, DISABILITY OR RETIREMENT OF
OPTIONEE OR A CHANGE IN CONTROL. If (i) an Optionee shall die while
employed by the Company or an Affiliate Corporation thereof, (ii) an Optionee
shall die within three (3) months after the termination of such Optionee's
employment, (iii) the Optionee's employment shall terminate by reason of
Disability or Retirement, or (iv) there is a Change in Control, then in any
such case all options theretofore granted to such Optionee (whether or not
then exercisable) may, unless earlier terminated or expired in accordance with
their terms, be exercised by the Optionee or by the Optionee's estate or by a
person who acquired the right to exercise such Option by bequest or
inheritance or otherwise by reason of the death or Disability of the Optionee,
at any time within one year after the date of death, Disability or Retirement
of the Optionee or the Change in Control.
(h) NONTRANSFERABILITY OF OPTIONS. Options granted under the Plan shall
not be transferable otherwise than by will or by the laws of descent and
distribution, and Options may be exercised, during the lifetime of the
Optionee, only by the Optionee or by his guardian or legal representative.
(i) EFFECT OF CERTAIN CHANGES.
(1) If there is any change in the number of outstanding shares
of Common Stock by reason of any stock dividend, a stock split,
recapitalization, combination, exchange of shares, merger, consolidation,
liquidation, split-up, spin-off or other similar change in capitalization, any
distribution to common shareholders, including a rights offering, other than
cash dividends, or any like change, then the number of shares of Common Stock
available for Options and Rights, the number of such shares covered by
outstanding Options and Rights, and the price per share of such Options or the
applicable market value of Rights, shall be proportionately adjusted by the
Committee to reflect such change or distribution; provided, however, that any
fractional shares resulting from such adjustment shall be eliminated.
(2) In the event of a change in the Common Stock of the Company
as presently constituted, which is limited to a change of all of its
authorized share with par value into the same number of shares with a
different par value or without par value, the shares resulting from any such
change shall be deemed to be the Common Stock within the meaning of the Plan.
(3) To the extent that the foregoing adjustment relate to stock
or securities of the Company, such adjustments shall be made by the Committee,
whose determination in that respect shall be final, binding and conclusive,
provided that each Inventive Stock Option granted pursuant to this Plan shall
not be adjusted in a manner that causes such option to fail to continue to
qualify as an Incentive Stock Option within the meaning of Section 422 of Code.
(j) RIGHTS AS A STOCKHOLDER. An Optionee or a transferee of an Option
shall have not rights as a stockholder with respect to any shares covered by
the Option until the date of the issuance of a stock certificate to him for
such shares. No adjustment shall be made for dividends (ordinary or
extraordinary, whether in cash, securities or other property) or distribution
of other rights for which the record date is prior to the date such stock
certificate is issued, except as provided in Section 8(i) hereof.
(k) OTHER PROVISIONS. The Option Agreements authorized under the Plan
shall contain such other provisions, including, without limitation, (i) the
granting of Rights, (ii) the imposition of restrictions upon the exercise of
an Option, and (iii) in the case of an Incentive Stock Option, the inclusion
of any condition not inconsistent with such Option qualifying as an Incentive
Stock Option, as the Committee shall deem advisable.
9. Stock Appreciation Rights.
(a) Grant and Exercise. In the case of a Nonqualified Stock Option,
Related Rights may be granted either at or after the time of the grant of such
Option. In the case for an Incentive Stock Option, related Rights may be
granted only at the time of the grant of the Incentive Stock Option.
A Related Right or applicable portion thereof granted with
respect to a given Option shall terminate and no longer be exercisable upon
the termination or exercise of the related Option, except that, unless
otherwise provided by the Committee at the time of grant, a Related Right
granted with respect to less than the full number of shares covered by a
related Option shall only be reduced if and to the extent that the number of
shares covered by the exercise or termination of the related Option exceeds
the number of shares not covered by the Right.
A Related Right may be exercised by an Optionee, in accordance
with paragraph (b) of this Section 9, by surrendering the applicable portion
of the related Option. Upon such exercise and surrender, the Optionee shall
be entitled to receive an amount determined in the manner prescribed in
paragraph (b) of this Section 9. Options which have been so surrendered, in
whole or in part, shall no longer be exercisable to the extent the Related
Rights have been exercised.
(b) Terms and Conditions. Rights shall be subject to such terms and
conditions, not inconsistent with the provisions of the Plan, as shall be
determined from time to time by the Committee and as evidenced by a written
Option Agreement between the Company and the Optionee, including the following:
(1) Related Rights shall be exercisable only at such time or
times and to the extent that the Options to which they relate shall be
exercisable in accordance with the provisions of Section 6, 7, 8 and this
Section 9 of the Plan; provided, however, that any related right shall not be
exercisable during the first six (6) months of the term of the Related Right,
except that this additional limitation shall not apply in the event of death
of the Optionee prior to the expiration of the six (6) month period.
(2) Upon the exercise of a Related Right, an Optionee shall be
entitled to receive up to, but not more than, an amount in cash or shares of
Common Stock equal in value to the excess of the Fair Market Value of one (1)
share of Common Stock over the option price per share specified in the related
Option multiplied by the number of shares in respect of which the Related
Right shall have been exercised, with the Committee having the right to
determine the form of payment.
(3) Related Rights shall be transferable only when and to the
extent that the underlying Option would be transferable under paragraph (h) of
Section 8 of the Plan.
(4) A Related Right granted in connection with an Incentive
Stock Option may be exercised only if and when the market price of the Common
Stock subject to the Incentive Stock Option exceeds the exercise price of such
Option.
(5) Free Standing Rights shall be exercisable at such time or
times and subject to such terms and conditions as shall be determined by the
Committee at or after grant; provided, however, that Free Standing Rights
shall not be exercisable during the first (6) six months of the term of the
Free Standing Right, except that this limitation shall not apply in the event
of death of the recipient of the Free Standing Right prior to the expiration
of the six-month period.
(6) The term of each Free Standing Right shall be fixed by the
Committee, but no Free Standing Right shall be exercisable more than ten (10)
years after the date such right is granted.
(7) Upon the exercise of a Free Standing Right, a recipient
shall be entitled to receive up to, but not more than, an amount in cash or
shares of Common Stock equal in value to the excess of the Fair Market Value
of one share of Common Stock over the price per share specified in the Free
Standing Right (which shall be no less than one hundred percent (100%) of the
Fair Market Value of the Common Stock on the date of grant) multiplied by the
number of shares in respect of which the right is being exercised, with the
Committee having the right to determine the form of payment.
(8) No Free Standing Right shall be transferable by the
recipient otherwise than by will or by the laws of descent and distribution,
and all such rights shall be exercisable, during the recipient's lifetime,
only by the recipient or his legal guardian or legal representative.
(9) In the event of the termination of employment of a
recipient of a Free Standing Right, such right shall be exercisable to the
same extent that an Option would have been exercisable in the event of the
termination of employment of an Optionee.
10. Agreement by Optionee Regarding Withholding Taxes.
If the Committee shall so require, as a condition of exercise,
each Optionee shall agree that:
(a) no later than the date of exercise of any Option or Right granted
hereunder, the Optionee will pay to the Company or make arrangements
satisfactory to the Committee regarding payment of any federal, state or local
taxes of any kind required by law to be withheld upon the exercise of such
Option or Right (any such tax, a "Withholding Tax"); and
(b) the Company shall, to the extent permitted or required by law, have
the right to deduct any Withholding Tax from any payment of any kind otherwise
due to the Optionee.
11. Gross-Up for Excise Tax.
An Option Agreement may provide that in the event that an
Optionee becomes entitled by reason of a Change of Control to the accelerated
vesting of an Option, if such Optionee will be subject to the excise tax (the
"Excise Tax") under Section 4999 of the Code, the Company shall pay to such
Optionee as additional compensation an amount (the "Gross-Up Payment") which,
after taking into account any federal, state and local income tax and Excise
Tax upon the payment provided for by this Section 10, shall be equal to the
amount of such Excise Tax. For purposes of determining whether an Optionee
will be subject to the Excise Tax and the amount of such Excise Tax, (i) any
other payments or benefits received or to be received by such Optionee in
connection with a Change in Control of the Company or the Optionee's
termination of employment (whether pursuant to the terms of the Option
Agreement or any other plan, arrangement or agreement with the Company, any
entity whose actions result in a Change in Control of the Company or any
entity affiliated with the Company or such entity) shall be treated as
"parachute payments" within the meaning of Section 280G(b)(2) of the Code, and
all "excess parachute payments" within the meaning of Section 280G(b)(1) of
the Code shall be treated as subject to the Excise Tax, unless in the opinion
of tax counsel selected by the Company's independent auditors and reasonably
acceptable to the Optionee such other payments or benefits (in whole or in
part) do not constitute parachute payments, including by reason of Section
280G(b)(4)(A) of the Code, or such excess parachute payments (in whole or in
part) represent reasonable compensation for services actually rendered, within
the meaning of Section 280G(b)(4)(B) of the Code, or are otherwise not subject
to the Excise Tax, (ii) the amount of payments or benefits treated as subject
to the Excise Tax shall be equal to the lesser of (A) the total amount of
payments or benefits conferred on such Optionee by reason of the Change of
Control or (B) the amount of excess parachute payments within the meaning of
Section 280G(b)(1) of the Code (after applying clause (i), above), and (iii)
the value of any noncash benefits or any deferred payment or benefit shall be
determined by the Company's independent auditors in accordance with the
principles of Sections 280G(d)(3) and (4) of the Code. For purposes of
determining the amount of the Gross-Up Payment, the Optionee shall be deemed
to pay federal income taxes at the highest marginal rate of federal income
taxation in the calendar year in which the Gross-Up Payment is to be made and
state and local income taxes at the highest marginal rate of taxation in the
state and locality of the Optionee's residence on the date on which the Excise
Tax is incurred, net of the maximum reduction in federal income taxes which
could be obtained from deduction of such state and local taxes. In the event
that the Excise Tax is subsequently determined to be less than the amount
taken into account hereunder, the Optionee shall repay to the Company, at the
time that the amount of such reduction in Excise Tax is finally determined,
the portion of the Gross-Up Payment attributable to such reduction (plus that
portion of the Gross-Up Payment attributable to the Excise Tax and federal,
state and local income tax deduction) plus interest on the amount of such
repayment at the rate provided in Section 1274(b)(2)(B) of the Code. In the
event that the Excise Tax is determined to exceed the amount taken into
account hereunder (including by reason of any payment the existence or amount
of which cannot be determined at the time of the Gross-Up Payment), the
Company shall make an additional Gross-Up Payment in respect of such excess
(plus any interest, penalties or additions payable by the Optionee with
respect to such excess) at the time that the amount of such excess finally is
determined. The Optionee and the Company each shall reasonably cooperate with
the other in connection with any administrative or judicial proceedings
concerning the existence or amount of liability for Excise Tax.
12. Termination and Amendment.
Unless terminated by action of the Board of Directors or the
Committee, no options may be granted under the Plan after May 19, 2007. The
Plan may be amended or terminated at any time by the Committee, except that
no amendment may be made without shareholder approval if the Committee
determines that such approval is necessary to comply with any tax or
regulatory requirement, including any approval requirement which is a
prerequisite for exemptive relief from Section 16 of the 1934 Act, for which
or with which the Committee determines that it is desirable to qualify or
comply. The Committee may amend the terms of any option granted,
retroactively or prospectively, but no amendment may adversely affect any
vested option without the holder's consent.
13. Effectiveness; Approval of Stockholders.
The Plan shall take effect upon its adoption by the Board of
Directors, but its effectiveness and the exercise of any Options or Rights
shall be subject to the approval of the holders of a majority of the voting
shares of the Company, which approval must occur within twelve (12) months
after the date the Plan is adopted by the Board.
14. Effect of Headings.
The section and subsection headings contained herein are for
convenience only and shall not affect the construction hereof.
EXHIBIT 5
November 7, 1997
Laboratory Corporation of America Holdings
358 South Main Street
Burlington, North Carolina 27215
Ladies and Gentlemen:
We are acting as special counsel for Laboratory Corporation of
America Holdings in connection with the filing of a Registration Statement
(the "Registration Statement") on Form S-8 under the Securities Act of 1933, as
amended, relating to 6,000,000 shares of common stock, par value $0.01 per
share (the "Common Stock"), deliverable in accordance with the Laboratory
Corporation of America Holdings Corp 1997 Stock Option Plan as referred to in
such Form S-8 (the "Plan").
We have examined originals or copies, certified or otherwise
identified to our satisfaction, of such documents, corporate records,
certificates of public officials and other instruments relating to the
adoption and amendment of the Plan as we have deemed necessary or advisable
for the purposes of this opinion.
Upon the basis of the foregoing, we are of the opinion that the
Common Stock deliverable pursuant to the Plan, when delivered in accordance
with the Plan will be duly authorized, validly issued, fully paid and
nonassessable.
We consent to the filing of this opinion as Exhibit 5 to the
Registration Statement.
Very truly yours,
/s/ Davis Polk & Wardwell
EXHIBIT 23.1
INDEPENDENT AUDITORS' CONSENT
The Board of Directors
Laboratory Corporation of America Holdings
We consent to the use of our reports incorporated herein by reference.
/s/ KPMG Peat Marwick LLP
Raleigh, North Carolina
November 5, 1997
EXHIBIT 24
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ Wesley R. Elingburg
----------------------------------
WESLEY R. ELINGBURG
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ Jean-Luc Belingard
----------------------------------
JEAN-LUC BELINGARD
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ Wendy E. Lane
----------------------------------
WENDY E. LANE
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ Robert E. Mittelstaedt, Jr.
----------------------------------
ROBERT E. MITTELSTAEDT, JR.
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ James B. Powell, M.D.
----------------------------------
JAMES B. POWELL, M.D.
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ David B. Skinner, M.D.
----------------------------------
DAVID B. SKINNER, M.D.
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned, in his or
her capacity or capacities as an officer or director or both of Laboratory
Corporation of America Holdings does hereby constitute and appoint Thomas P.
Mac Mahon, the true and lawful attorney and agent of the undersigned, each
with power of substitution, to do any and all acts and things for and on
behalf of the undersigned and in the name of the undersigned and in the
capacity or capacities of the undersigned as aforesaid and to execute any and
all instruments for and on behalf of the undersigned and in the name of the
undersigned, which said attorneys and agents, or either of them, may deem
necessary or advisable to enable said corporation to comply with the
Securities Act of 1933, as amended, and any rules, regulations, and
requirements of the Securities and Exchange Commission, in connection with this
Registration Statement, including specifically but without limitation, power
and authority to sign for the undersigned in the capacities indicated below,
any and all amendments (including post-effective amendments) hereto; and the
undersigned does hereby ratify and confirm all that the said attorneys and
agents, or their substitute or substitutes, or either of them, shall do or
cause to be done by virtue hereof.
IN WITNESS WHEREOF, the undersigned has executed this power of
attorney this 1st day of July, 1997.
/s/ Andrew G. Wallace, M.D.
----------------------------------
ANDREW G. WALLACE, M.D.
